Metformin in Safety and Efficacy in Gouty Patients
Launched by MOSTAFA BAHAA · Apr 5, 2025
Trial Information
Current as of July 24, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the use of a medication called metformin to see if it can help patients with gout, a condition that causes severe pain and swelling in the joints. Gout can significantly affect a person's quality of life, leading to difficulties in daily activities. Metformin is commonly used to treat diabetes by helping the body use insulin better, and researchers want to find out if it can also be beneficial for people suffering from gout.
To participate in this trial, individuals must be diagnosed with gouty arthritis based on specific medical criteria. However, there are some people who cannot join, such as those with certain serious health conditions like heart or brain disorders, or those taking specific medications. Participants will be closely monitored throughout the trial to assess how well metformin works for managing their gout symptoms. This trial is not yet recruiting, but it aims to provide valuable information on a potential new treatment option for those struggling with gout.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Gouty patients clinically diagnosed as gouty arthritis based on the American College of Rheumatology/European League Against Rheumatism criteria of gout.
- Exclusion Criteria:
- • Systemic disorders such as cardiovascular, neurological, coronary artery disease.
- • Hypertension, hyperlipidemia, diabetes mellitus, active infections.
- • Other inflammatory or autoimmune diseases.
- • Patients on biologics,
- • Cases with hypersensitivity to metformin and those with impaired liver and kidney functions.
About Mostafa Bahaa
Mostafa Bahaa is a dedicated clinical trial sponsor committed to advancing medical research and patient care through rigorous and ethical clinical studies. With a focus on innovative therapeutic solutions, the organization collaborates with leading researchers and healthcare institutions to ensure the highest standards of scientific integrity and regulatory compliance. Mostafa Bahaa prioritizes patient safety and data transparency, striving to contribute valuable insights that enhance treatment options and improve health outcomes across diverse medical fields.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tanta, , Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported